Neural tube defects, in particular spina bifida and anencephaly, are serious and relatively com m on con gen ital abnormalities worldwide. They also occur in South Africa and affect all population groups to varying degrees. The overall incidence in South Africa is approximately 1-2 per 1000 newborns. Higher incidences, up to 6 per 1000 newborns have been recorded in certain parts, especially in some rural areas of the country. In total as many as 1500 newborns could be affected by a neural tube defect each year. The precise aetiology of neural tube defects is still unknown.
Most anencephalic babies are stillborn and the remainder usually die within the first day. The mortality rate among patients with spina bifida is high. Many such patients can be treated, which in clu d es r e p ea ted surgery and hospitalization, as well as antibiotic and orthopaedic management. Although treatment may be successful, most children with spina bifida will remain handicapped to a greater or lesser degree, both physically and/or mentally. They will continue to require life-long supportive medical services and care, as well as special schooling.
The Department of National Health and Population Developm ent ranks the prevention of neural tube defects as a high health service priority and fully supports measures designed for the prevention of neural tube defects. One such method of prevention is by way of maternal serum screening tests and prenatal diagnosis. W hereas this procedure remains an important option for women who have access to such screening and diagnostic services, a new supplem entary m ethod of primary p reven tion has recen tly b ecom e availab le. E xp erim ental and epidemiological evidence has shown that periconceptual dietary supplementation with folic acid can substantially decrease the incidence of neural tube defects. Based on these scientific results, health authorities and professional bodies in various countries have oficially expressed themselves in favour of periconceptual dietary folic acid supplementation to substantially reduce the risk of babies being affected with neural tube defects.
The Department of National Health and Population Development has taken note of this important development and especially of the scientific evidence in support of the recommended procedure (see publications listed below). In view of the proven beneficial effect of folic acid supplementation on the reduction of the incidence of neural tube defects, this Department strongly recommends that all women of childbearing age be inform ed o f the b en efits of p erico n cep tu a l fo lic acid supplementation and be encouraged to make use of this treatment. In particular, it is recommended that women who already had a baby or close family member affected with a neural tube defect, be advised to use folic acid supplementation periconceptually when planning a subsequent pregnancy. A ccord in g to published recom m en dations all wom en of childbearing age who are capable of becoming pregnant should consume 0,4 mg of folic acid per day for the purpose of reducing their risk of having a pregnancy aJffected with a neiu-al tube defect. It is trusted that the medical p ro fessio n , other health service providers and authorities countrywide will support the endeavour to reduce the risk for neural tube defects by the way of the procedure as recommended.
